Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Clinical trial NCT05225116 · UNKNOWN
Trial details
- NCT number
- NCT05225116
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-08
- Primary completion
- 2025-12-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.